Phosphorylated AMP-activated protein kinase expression associated with prognosis for patients with gastric cancer treated with cisplatin-based adjuvant chemotherapy

被引：0
|
作者：
Byung Woog Kang
Ji Yun Jeong
Yee Soo Chae
Soo Jung Lee
Yoo Jin Lee
Jun Young Choi
In-Kyu Lee
Seong Woo Jeon
Han Ik Bae
Da Keun Lee
Oh-kyoung Kwon
Ho Young Chung
Wansik Yu
Jong Gwang Kim
机构：
[1] Kyungpook National University School of Medicine,Department of Hematology/Oncology, Kyungpook National University Hospital
[2] Kyungpook National University School of Medicine,Department of Endocrinology, Kyungpook National University Hospital
[3] Kyungpook National University School of Medicine,Department of Gastroenterology, Kyungpook National University Hospital
[4] Kyungpook National University School of Medicine,Department of Pathology, Kyungpook National University Hospital
[5] Kyungpook National University School of Medicine,Department of Surgery, Kyungpook National University Hospital
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 70卷
关键词：
AMP-activated protein kinase; Gastric cancer; Cisplatin; Adjuvant chemotherapy; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：735 / 741
页数：6
相关论文
共 50 条
  • [1] Phosphorylated AMP-activated protein kinase expression associated with prognosis for patients with gastric cancer treated with cisplatin-based adjuvant chemotherapy
    Kang, Byung Woog
    Jeong, Ji Yun
    Chae, Yee Soo
    Lee, Soo Jung
    Lee, Yoo Jin
    Choi, Jun Young
    Lee, In-Kyu
    Jeon, Seong Woo
    Bae, Han Ik
    Lee, Da Keun
    Kwon, Oh-Kyoung
    Chung, Ho Young
    Yu, Wansik
    Kim, Jong Gwang
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (05) : 735 - 741
  • [2] Association between Phosphorylated AMP-Activated Protein Kinase and MAPK3/1 Expression and Prognosis for Patients with Gastric Cancer
    Kim, Jong Gwang
    Lee, Soo Jung
    Chae, Yee Soo
    Kang, Byung Woog
    Lee, You Jin
    Oh, Sung Yong
    Kim, Min Chan
    Kim, Ki Han
    Kim, Su-Jin
    ONCOLOGY, 2013, 85 (02) : 78 - 85
  • [3] The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival
    William, W. N.
    Kim, J. -S.
    Liu, D. D.
    Solis, L.
    Behrens, C.
    Lee, J. J.
    Lippman, S. M.
    Kim, E. S.
    Hong, W. K.
    Wistuba, I. I.
    Lee, H. -Y.
    ANNALS OF ONCOLOGY, 2012, 23 (01) : 78 - 85
  • [4] ERCC1 predicts outcome in patients with gastric cancer treated with adjuvant cisplatin-based chemotherapy
    De Dosso, Sara
    Zanellato, Elena
    Nucifora, Martina
    Boldorini, Renzo
    Sonzogni, Angelica
    Biffi, Roberto
    Fazio, Nicola
    Bucci, Eraldo
    Beretta, Ottavio
    Crippa, Stefano
    Saletti, Piercarlo
    Frattini, Milo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (01) : 159 - 165
  • [5] Phosphorylated AMP-activated protein kinase expression is significantly associated with poor clinical outcomes in bladder carcinoma patients
    Al-Maghrabi, Jaudah
    Qureshi, Imtiaz Ahmad
    Butt, Nadeem Shafique
    Khabaz, Mohamad Nidal
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (07): : 3718 - 3725
  • [6] ERCC1 predicts outcome in patients with gastric cancer treated with adjuvant cisplatin-based chemotherapy
    Sara De Dosso
    Elena Zanellato
    Martina Nucifora
    Renzo Boldorini
    Angelica Sonzogni
    Roberto Biffi
    Nicola Fazio
    Eraldo Bucci
    Ottavio Beretta
    Stefano Crippa
    Piercarlo Saletti
    Milo Frattini
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 159 - 165
  • [7] Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy
    Kim, Jong Gwang
    Ryoo, Baek-Yeol
    Park, Yeon Hee
    Kim, Bong-Seog
    Kim, Tae-You
    Im, Young-Hyuck
    Kang, Yoon-Koo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (02) : 301 - 307
  • [8] Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy
    Jong Gwang Kim
    Baek-Yeol Ryoo
    Yeon Hee Park
    Bong-Seog Kim
    Tae-You Kim
    Young-Hyuck Im
    Yoon-Koo Kang
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 301 - 307
  • [9] Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy
    Keck, Bastian
    Wach, Sven
    Stoehr, Robert
    Kunath, Frank
    Bertz, Simone
    Lehmann, Jan
    Stoeckle, Michael
    Taubert, Helge
    Wullich, Bernd
    Hartmann, Arndt
    BMC CANCER, 2013, 13
  • [10] Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy
    Bastian Keck
    Sven Wach
    Robert Stoehr
    Frank Kunath
    Simone Bertz
    Jan Lehmann
    Michael Stöckle
    Helge Taubert
    Bernd Wullich
    Arndt Hartmann
    BMC Cancer, 13
12345